The influence of dizocilpine (MK-801) on the reserpine-enhanced electromyographic stretch reflex in rats

Neuroscience Letters

Volumn 203, Issue 2, 1996, Pages 73-76

  Ossowska, Krystyna ^a   Lorenc Koci, Elzbieta ^a   Schulze, Gert ^b   Wolfarth, Stanisław ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Electromyogram; MK 801; NMDA receptors; Parkinsonian rigidity; Rat; Reserpine; Stretch reflex

Indexed keywords

DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; RESERPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ELECTROMYOGRAM; GASTROCNEMIUS MUSCLE; MALE; MYOTATIC REFLEX; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; RIGIDITY; SUBCUTANEOUS DRUG ADMINISTRATION; TIBIALIS ANTERIOR MUSCLE;

EID: 0029671247     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(95)12264-8     Document Type: Article

References (31)

1. Bean, A.J., Adrian, T.E., Modlin, I.M. and Roth, R.H., Dopamine and neurotensin storage in colocalized and non-colocalized neuronal populations, J. Pharmacol. Exp. Ther., 249 (1989) 681-687.
2. Bergui, M., Lopiano, L., Paglia, G., Quattrocolo, G., Scarzella, L. and Bergamasco, B., Stretch reflex of quadriceps femoris and its relation to rigidity in Parkinson's disease, Acta Neurol. Scand., 86 (1992) 226-229.
3. Berardelli, A., Sabra, A.F. and Hallet, M., Physiological mechanisms of rigidity in Parkinson's disease, J. Neurol. Neurosurg. Psychiatry, 46 (1983) 45-53.
4. Davidoff, R.A., Skeletal muscle tone and the misunderstood stretch reflex, Neurology, 42 (1992) 951-963.
5. Delwaide, P.J., Sabbatino, M. and Delwaide, C., Some pathophysiological aspects of the parkinsonian rigidity, J. Neural Transm., 22 (1986) 129-139.
6. Elverfors, A. and Nissbrandt, H., Reserpine-insensitive dopamine release in the substantia nigra? Brain Res., 557 (1991) 5-12.
7. Fornstedt, B. and Carlsson, A., A marked rise in 5-5-cysteinyl-dopamine levels in guinea-pig striatum following reserpine treatment, J. Neural Transm., 76 (1989) 155-161.
8. Grossman, W., Juma, I., Nell, T. and Theres, C., The dependence of the anti-nociceptive effect of morphine and other analgetic agents on spinal motor activity after central monoamine depletion, Eur. J. Pharmacol., 24 (1973) 67-77.
9. Klockgether, T. and Turski, L., Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease, Trends Neurosci., 12 (1989) 285-286.
10. Klockgether, T. and Turski, L., NMDA antagonists potentiate antiparkinsonian actions of L-DOPA in monoamine-depleted rats. Ann. Neurol., 28 (1990) 539-546.
11. Klockgether, T. and Turski, L., Toward an understanding of the role of glutamate in experimental parkinsonism: agonist-sensitive sites in the basal ganglia, Ann. Neurol., 34 (1993) 585-593.
12. Kolasiewicz, W., Baran, J. and Wolfarth, S., Mechanographic analysis of muscle rigidity after morphine and haloperidol: a new methodological approach, Naunyn-Schmiedebergs Arch. Pharmacol., 335 (1987) 449-453.
13. 3]MK-801 at therapeutic concentrations in postmortem human frontal cortex, Eur. J. Pharmacol., 166 (1989) 589-590.
14. Kornhuber, J., Bormann, J., Hübers, M., Rusche, K. and Riederer, P., Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study, Eur. J. Pharmacol. (Mol. Pharmacol. Sect.), 206 (1991) 297-300.
15. Lee, R.G., Pathophysiology of rigidity and akinesia in Parkinson's disease, Eur. Neurol., 29 (Suppl. 1) (1989) 13-18.
16. Lee, R.G. and Tatton, W.G., Motor responses to sudden limb displacements in primates with specific CNS lesions and in human patients with motor system disorders. Can. J. Neurol. Sci., 2 (1975) 285-293.
17. Lorenc-Koci, E., Ossowska, K., Wardas, J. and Wolfarth, S., Does reserpine induce parkinsonian rigidity? J. Neural Transm. (P.D. Sect.), 9 (1995) 211-223.
18. Marsden, C.D., Merton, P.A. and Morton, H.B., Is the human stretch reflex cortical rather than spinal? Lancet, (1973) 759-761.
19. Matthews, P.B., The human stretch reflex and the motor cortex, Trends Neurosci., 14 (1991) 87-91.
20. Meara, R.J. and Cody, F.W.J., Relationship between electromyographic activity and clinically assessed rigidity at the wrist joint in Parkinson's disease, Brain, 115 (1992) 1167-1180.
21. Mortimer, J.A. and Webster, D.D., Evidence for a quantitative association between EMG stretch responses and parkinsonian rigidity, Brain Res., 162 (1979) 169-173.
22. Ossowska, K., The role of excitatory amino acids in experimental models of Parkinson's disease, J. Neural Transm. (P.D. Sect.), 8 (1994) 39-71.
23. Ossowska, K., Lorenc-Koci, E. and Wolfarth, S., Antiparkinsonian action of MK-801 on the reserpine-induced rigidity: a mechanomyographic analysis, J. Neural Transm. (P.D. Sect.), 7 (1994) 143-152.
24. Porter, R.H.P. and Greenamyre, J.T., Regional variations in the pharmacology of NMDA receptor channel blockers: implications for therapeutic potential, J. Neurochem., 64 (1995) 614-623.
25. Rabey, J.M., Nissipeanu, P. and Korczyn, A.D., Efficacy of memantine, an NMDA receptor antagonist in the treatment of Parkinson's disease, J. Neural Transm. (P.D. Sect.), 4 (1992) 277-282.
26. Riederer, P., Lange, K.W., Kornhuber, J. and Jellinger, K., Glutamate receptor antagonism: neurotoxicity, anti-akinetic effects, and psychosis, J. Neural Transm. (Suppl.), 34 (1991) 203-210.
27. Riederer, P., Lange, K.W., Kornhuber, J. and Danielczyk, W., Glutamatergic-dopaminergic balance in the brain, Arzneimittelforschung/Drug Res., 42 (I) (1992) 265-268.
28. Rothwell, J.C., Obeso, J.A., Traub, M.M. and Marsden, C.D., The behaviour of the long-latency stretch reflex in patients with Parkinson's disease, J. Neurol. Neurosurg. Psychiatry, 46 (1983) 35-44.
29. Schneider, E., Fischer, P.A., Clemens, R., Balzereit, F., Funfgeld, E.W. and Haase, H.J., Effects of oral memantine administration on Parkinson symptoms: results of placebo-controlled multicenter study, Dtsch. Med. Wochenschr., 109 (1984) 987-990.
30. Scholz, E., Diener, H.C., Noth, J., Friedemann, H., Dichgans, J. and Bacher, M., Medium and long latency EMG responses in leg muscles: Parkinson's disease, J. Neurol. Neurosurg. Psychiatry, 50 (1987) 66-70.
31. Schwab, R.S., England, A.C., Poskanzer, D.C. and Young, R.R., Amantadine in the treatment of Parkinson's disease, JAMA, 208 (1969) 1168-1170.